{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:25:33Z","timestamp":1787243133917,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"South-Eastern Norway Health Authorities","award":["2022066"],"award-info":[{"award-number":["2022066"]}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40266-026-01286-w","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:00:31Z","timestamp":1773396031000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Anticholinergic Burden and Dry Mouth Severity in Acutely Ill Older Adults"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0090-349X","authenticated-orcid":false,"given":"Ingrid Beate","family":"Ringstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-6141","authenticated-orcid":false,"given":"Eva","family":"Skovlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3615-6401","authenticated-orcid":false,"given":"Leonor","family":"Roa Santervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-5985","authenticated-orcid":false,"given":"Hege","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3368-6018","authenticated-orcid":false,"given":"Katrine Gahre","family":"Fjeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-5065","authenticated-orcid":false,"given":"Lene Hystad","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-9471","authenticated-orcid":false,"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4276-9611","authenticated-orcid":false,"given":"Janicke Liaaen","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3251-6349","authenticated-orcid":false,"given":"Rita","family":"Romskaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"1","key":"1286_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-016-0153-9","volume":"17","author":"A Wolff","year":"2017","unstructured":"Wolff A, Joshi RK, Ekstr\u00f6m J, Aframian D, Pedersen AM, Proctor G, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2017;17(1):1\u201328.","journal-title":"Drugs R D."},{"issue":"1","key":"1286_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ageing\/afaa099","volume":"50","author":"WM Thomson","year":"2021","unstructured":"Thomson WM, Ferguson CA, Janssens BE, Kerse NM, Ting GS, Smith MB. Xerostomia and polypharmacy among dependent older New Zealanders: a national survey. Age Ageing. 2021;50(1):248\u201351.","journal-title":"Age Ageing"},{"issue":"7","key":"1286_CR3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00784-015-1488-2","volume":"19","author":"A Villa","year":"2015","unstructured":"Villa A, Wolff A, Aframian D, Vissink A, Ekstr\u00f6m J, Proctor G, et al. World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19(7):1563\u201380.","journal-title":"Clin Oral Investig"},{"issue":"4","key":"1286_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","volume":"9","author":"C Scully","year":"2003","unstructured":"Scully C. Drug effects on salivary glands: dry mouth. Oral Dis. 2003;9(4):165\u201376.","journal-title":"Oral Dis"},{"issue":"2","key":"1286_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00002512-199915020-00004","volume":"15","author":"TO N\u00e4rhi","year":"1999","unstructured":"N\u00e4rhi TO, Meurman JH, Ainamo A. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging. 1999;15(2):103\u201316.","journal-title":"Drugs Aging"},{"issue":"2","key":"1286_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cden.2015.11.003","volume":"60","author":"MD Turner","year":"2016","unstructured":"Turner MD. Hyposalivation and xerostomia: etiology, complications, and medical management. Dent Clin N Am. 2016;60(2):435\u201343.","journal-title":"Dent Clin N Am"},{"issue":"2","key":"1286_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/jomfp.JOMFP_231_16","volume":"21","author":"SD Nadig","year":"2017","unstructured":"Nadig SD, Ashwathappa DT, Manjunath M, Krishna S, Annaji AG, Shivaprakash PK. A relationship between salivary flow rates and Candida counts in patients with xerostomia. J Oral Maxillofac Pathol. 2017;21(2):316.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"5","key":"1286_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036557","volume":"7","author":"K Solemdal","year":"2012","unstructured":"Solemdal K, Sandvik L, Willumsen T, Mowe M, Hummel T. The impact of oral health on taste ability in acutely hospitalized elderly. PLoS\u00a0One. 2012;7(5):e36557.","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"1286_CR9","first-page":"475","volume":"19","author":"K Ikebe","year":"2006","unstructured":"Ikebe K, Matsuda K, Morii K, Furuya-Yoshinaka M, Nokubi T, Renner RP. Association of masticatory performance with age, posterior occlusal contacts, occlusal force, and salivary flow in older adults. Int J Prosthodont. 2006;19(5):475\u201381.","journal-title":"Int J Prosthodont"},{"issue":"2","key":"1286_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ger.12123","volume":"33","author":"P Poisson","year":"2016","unstructured":"Poisson P, Laffond T, Campos S, Dupuis V, Bourdel-Marchasson I. Relationships between oral health, dysphagia and undernutrition in hospitalised elderly patients. Gerodontology. 2016;33(2):161\u20138.","journal-title":"Gerodontology"},{"issue":"2","key":"1286_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00784-010-0382-1","volume":"15","author":"GJ van der Putten","year":"2011","unstructured":"van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011;15(2):185\u201392.","journal-title":"Clin Oral Investig"},{"issue":"6","key":"1286_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1517\/14740338.2016.1165664","volume":"15","author":"PS Nishtala","year":"2016","unstructured":"Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753\u201368.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"1286_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00002512-199303040-00004","volume":"3","author":"M Feinberg","year":"1993","unstructured":"Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging. 1993;3(4):335\u201348.","journal-title":"Drugs Aging"},{"issue":"9","key":"1286_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/014107680009300903","volume":"93","author":"J Mintzer","year":"2000","unstructured":"Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000;93(9):457\u201362.","journal-title":"J R Soc Med"},{"issue":"2","key":"1286_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555\u201363.","journal-title":"Behav Brain Res"},{"issue":"11","key":"1286_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/1060028015596998","volume":"49","author":"ZA Marcum","year":"2015","unstructured":"Marcum ZA, Perera S, Thorpe JM, Switzer GE, Gray SL, Castle NG, et al. Anticholinergic use and recurrent falls in community-dwelling older adults: findings from the health ABC Study. Ann Pharmacother. 2015;49(11):1214\u201321.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"1286_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401\u20137.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"1286_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc. 2011;59(8):1477\u201383.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1286_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508\u201313.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1286_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1365-2125.2012.04411.x","volume":"75","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Willumsen T, Engedal K, Bruun Wyller T. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol. 2013;75(3):842\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1286_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11096-020-01117-x","volume":"43","author":"M Lavrador","year":"2021","unstructured":"Lavrador M, Cabral AC, Figueiredo IV, Ver\u00edssimo MT, Castel-Branco MM, Fernandez-Llimos F. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients. Int J Clin Pharm. 2021;43(1):128\u201336.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"1286_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/gls176","volume":"68","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68(3):271\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"1286_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0528.1997.tb00928.x","volume":"25","author":"T Nederfors","year":"1997","unstructured":"Nederfors T, Isaksson R, M\u00f6rnstad H, Dahl\u00f6f C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol. 1997;25(3):211\u20136.","journal-title":"Community Dent Oral Epidemiol"},{"issue":"2","key":"1286_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/joor.12878","volume":"47","author":"AK Johansson","year":"2020","unstructured":"Johansson AK, Johansson A, Unell L, Ekb\u00e4ck G, Ordell S, Carlsson GE. Self-reported dry mouth in 50- to 80-year-old Swedes: longitudinal and cross-sectional population studies. J Oral Rehabil. 2020;47(2):246\u201354.","journal-title":"J Oral Rehabil"},{"issue":"1","key":"1286_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ger.12101","volume":"33","author":"Y Ohara","year":"2016","unstructured":"Ohara Y, Hirano H, Yoshida H, Obuchi S, Ihara K, Fujiwara Y, et al. Prevalence and factors associated with xerostomia and hyposalivation among community-dwelling older people in Japan. Gerodontology. 2016;33(1):20\u20137.","journal-title":"Gerodontology"},{"issue":"7","key":"1286_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022500","volume":"8","author":"CJ Byrne","year":"2018","unstructured":"Byrne CJ, Walsh C, Cahir C, Ryan C, Williams DJ, Bennett K. Anticholinergic and sedative drug burden in community-dwelling older people: a national database study. BMJ Open. 2018;8(7):e022500.","journal-title":"BMJ Open"},{"issue":"10","key":"1286_CR27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40266-019-00694-5","volume":"36","author":"BT Suehs","year":"2019","unstructured":"Suehs BT, Caplan EO, Hayden J, Ng DB, Gaddy RR. The relationship between anticholinergic exposure and falls, fractures, and mortality in patients with overactive bladder. Drugs Aging. 2019;36(10):957\u201367.","journal-title":"Drugs Aging"},{"issue":"21","key":"1286_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/app132111758","volume":"13","author":"J Frigaard","year":"2023","unstructured":"Frigaard J, Hynne H, Jensen JL. Development and proposal of a novel scoring system to classify dry mouth severity. Appl Sci Basel. 2023;13(21):11758.","journal-title":"Appl Sci Basel"},{"key":"1286_CR29","doi-asserted-by":"crossref","unstructured":"Ringstad IB, Romskaug R, Santervas LR, Fjeld KG, Hove LH, Skovlund E, et al. Oral health, xerogenic medications, and frailty in acutely ill older adults. J Am Geriatr Soc. 2025.","DOI":"10.1111\/jgs.19564"},{"key":"1286_CR30","unstructured":"King R, Rabino S. ACB calculator. 2025. https:\/\/www.acbcalc.com\/."},{"issue":"3","key":"1286_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. J Aging Health. 2008;4(3):311\u201320.","journal-title":"J Aging Health"},{"issue":"1","key":"1286_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18(1):239.","journal-title":"BMC Geriatr"},{"issue":"2","key":"1286_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00228-020-02994-x","volume":"77","author":"A Lisibach","year":"2021","unstructured":"Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. Eur J Clin Pharmacol. 2021;77(2):147\u201362.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1286_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1754-4505.1999.tb01363.x","volume":"19","author":"WM Thomson","year":"1999","unstructured":"Thomson WM, Chalmers JM, Spencer AJ, Ketabi M. The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians. Spec Care Dent. 1999;19(1):20\u20133.","journal-title":"Spec Care Dent"},{"issue":"3","key":"1286_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tripleo.2011.03.024","volume":"112","author":"WM Thomson","year":"2011","unstructured":"Thomson WM, van der Putten GJ, de Baat C, Ikebe K, Matsuda K, Enoki K, et al. Shortening the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):322\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"1286_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.oooo.2012.05.009","volume":"114","author":"SM Osailan","year":"2012","unstructured":"Osailan SM, Pramanik R, Shirlaw P, Proctor GB, Challacombe SJ. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):597\u2013603.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"1286_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0030-4220(88)90268-X","volume":"66","author":"LM Sreebny","year":"1988","unstructured":"Sreebny LM, Valdini A. Xerostomia. Part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol. 1988;66(4):451\u20138.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"1286_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35\u201345.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1286_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489\u201395.","journal-title":"CMAJ"},{"issue":"5","key":"1286_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"1","key":"1286_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ger.12304","volume":"35","author":"A Tiisanoja","year":"2018","unstructured":"Tiisanoja A, Syrj\u00e4l\u00e4 AM, Komulainen K, Lampela P, Hartikainen S, Taipale H, et al. Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults. Gerodontology. 2018;35(1):3\u201310.","journal-title":"Gerodontology"},{"issue":"1","key":"1286_CR42","doi-asserted-by":"publisher","first-page":"84.e5","DOI":"10.1016\/j.jamda.2011.04.001","volume":"13","author":"A Cherubini","year":"2012","unstructured":"Cherubini A, Eusebi P, Dell\u2019Aquila G, Landi F, Gasperini B, Bacuccoli R, et al. Predictors of hospitalization in Italian nursing home residents: the U.L.I.S.S.E. project. J Am Med Dir Assoc. 2012;13(1):84.e5-10.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1286_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jamda.2017.07.008","volume":"19","author":"B Bonaga","year":"2018","unstructured":"Bonaga B, S\u00e1nchez-Jurado PM, Mart\u00ednez-Reig M, Ariza G, Rodr\u00edguez-Ma\u00f1as L, Gnjidic D, et al. Frailty, polypharmacy, and health outcomes in older adults: the Frailty and Dependence in Albacete Study. J Am Med Dir Assoc. 2018;19(1):46\u201352.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"1286_CR44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/pds.2116","volume":"20","author":"J Jyrkk\u00e4","year":"2021","unstructured":"Jyrkk\u00e4 J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2021;20(5):514\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1286_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65989-9","volume":"10","author":"N Cebron Lipovec","year":"2020","unstructured":"Cebron Lipovec N, Jazbar J, Kos M. Anticholinergic burden in children, adults and older adults in Slovenia: a nationwide database study. Sci Rep. 2020;10(1):9337.","journal-title":"Sci Rep"},{"issue":"8","key":"1286_CR46","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/00016357.2022.2069282","volume":"80","author":"A Adolfsson","year":"2022","unstructured":"Adolfsson A, Len\u00e9r F, Marklund B, Mossberg K, \u00c7evik-Aras H. Prevalence of dry mouth in adult patients in primary health care. Acta Odontol Scand. 2022;80(8):605\u201310.","journal-title":"Acta Odontol Scand"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01286-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:03:11Z","timestamp":1774969391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01286-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01286-w","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Professor Torgeir Bruun Wyller has received lecture fees from the Novo Nordisk Foundation. All other authors declare they have no potential conflicts of interest that might be relevant to the contents of this manuscript. Professor Torgeir Bruun Wyller is an Editorial Board member of Drugs & Aging. Professor Torgeir Bruun Wyller was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets used and\/or analysed may be available from the corresponding author upon reasonable request, subject to approval by the Regional Committee for Medical and Health Research Ethics in Norway (REK).\n                      Ethical approval\n                      Ethical approval for the study was granted by the Regional Committee for Medical and Health Research Ethics of South-East Norway (approval no. REK 477258) and by the Data Protection Officer at Oslo University Hospital. The study adhered to the ethical standards of the University of Oslo, Oslo University Hospital, and complied with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Written informed consent was obtained from all individual participants included in the study. For those without decision-making capacity, consent was provided by the closest relative, in conjunction with the patient\u2019s assent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}